Fanny Duval

Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis

M. Haissaguerre, M. Kostine, C. Dutriaux, 2024, Frontiers in oncology.

Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors

M. Kostine, Emilie Gerard, Fanny Duval, 2023, Frontiers in oncology.

Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC)

S. Prey, A. Khammari, F. Aubin, 2023, Journal of neurology.